News

The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute

Researcher Isabelle Plo and Dr William Vainchenker, a haematologist and researcher at Gustave Roussy, have co-authored a landmark review on myeloproliferative neoplasms (MPNs), published in the New England Journal of Medicine on 19 August. The article summarises major advances in understanding these blood cancers and highlights therapeutic...

The Gold September awareness campaign, launched in France in 2016 at the initiative of Gustave Roussy, celebrates its tenth anniversary this year. Over the past decade, the campaign has enabled numerous large-scale scientific projects to be completed by raising funds to advance the understanding and treatment of childhood cancers

Awarded by the European Research Council, the ERC Starting Grant is a recognised mark of excellence. It provides funding for ambitious projects while giving researchers full scientific independence. This European Research Council grant recognises early-career scientists leading ambitious projects. It will enable Carlos Pérez González to develop...

Launched in France at the initiative of Gustave Roussy, September Gold, the awareness month dedicated to childhood and adolescent cancers, celebrates its 10th anniversary this year. To mark the occasion, Goûter en Or 2026, the flagship event of the campaign, will take place in numerous cities across France. In Paris, the Jardin d’Acclimatation...

« Great advances in oncology » - Episode 4/4. In 1952, Dr Odile Schweisguth established Europe’s first paediatric oncology department at Gustave Roussy, at a time when the specialty was largely overlooked. Until her retirement in 1978, she fought to ensure that childhood tumours received dedicated and appropriate care, both in France and...

Last quarter also brought several other noteworthy developments. Researchers reported that delivering part of chemotherapy more precisely after surgery can help treat liver metastases, that antibody drug conjugates (ADCs) provide an additional treatment option in certain metastatic breast cancers, that nuclear medicine is showing encouraging...

By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026.